At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,013 enrolled
Drug / intervention
PARADYM DR model 8550; PARADYM CRT model 8750; PARADYM RF DR model 9550; PARADYM RF CRT model 9750; PARADYM RF CRT SonR model 9770device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination
In Brief
A clinical study evaluating PARADYM DR model 8550; PARADYM CRT model 8750; PARADYM RF DR model 9550; PARADYM RF CRT model 9750; PARADYM RF CRT SonR model 9770 for Tachycardia. Completed, enrolled 1,013 participants across 80 sites in 7 countries.
Detailed Summary
ISIS- ICD study has been designed to evaluate the impact of PARAD+ algorithm on inappropriate shocks, in a general population implanted for primary or secondary prevention with a dual or tri chamber device at one year follow-up
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTachycardia
CountriesFrance, Germany, Italy, Japan, Spain, United Kingdom, United States
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedAug 2011
Enrollment StartOct 2011
Primary CompletionAug 2015
Study CompletionFeb 2016
TodayJul 2026
First PostedAug 5, 2011
Enrollment StartOct 1, 2011
Primary CompletionAug 1, 2015
Study CompletionFeb 1, 2016
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 14.9 years ago
Interventions
PARADYM DR model 8550; PARADYM CRT model 8750; PARADYM RF DR model 9550; PARADYM RF CRT model 9750; PARADYM RF CRT SonR model 9770device
PARADYM ICD and CRT-d with PARAD+ algorithm available